Bugs, Drugs, and HIV: the Role of the Vaginal Microbiome in HIV Risk and Antiretroviral Efficacy for HIV Prevention

Overview

Journal Genome Med

Publisher Biomed Central

Specialty Genetics

Date 2017 Aug 19

PMID 28818087

Citations 3

Authors

Lenine J P Liebenberg

Derseree Archary

Aida Sivro

Douglas S Kwon

Affiliations

Soon will be listed here.

Citing Articles

Inflammation, HIV, and Immune Quiescence: Leveraging on Immunomodulatory Products to Reduce HIV Susceptibility.

Cromarty R, Archary D AIDS Res Treat. 2020; 2020:8672850.

PMID: 33178456 PMC: 7609152. DOI: 10.1155/2020/8672850.

Diminished HIV Infection of Target CD4+ T Cells in a Toll-Like Receptor 4 Stimulated Model.

Cromarty R, Sigal A, Liebenberg L, McKinnon L, Abdool Karim S, Passmore J Front Immunol. 2019; 10:1705.

PMID: 31396221 PMC: 6664077. DOI: 10.3389/fimmu.2019.01705.

Rilpivirine Plasma and Cervicovaginal Concentrations in Women During Pregnancy and Postpartum.

Eke A, Chakhtoura N, Kashuba A, Best B, Sykes C, Wang J J Acquir Immune Defic Syndr. 2018; 78(3):308-313.

PMID: 29528944 PMC: 6002878. DOI: 10.1097/QAI.0000000000001677.

References

Myer L, Kuhn L, Stein Z, Wright Jr T, Denny L . Intravaginal practices, bacterial vaginosis, and women's susceptibility to HIV infection: epidemiological evidence and biological mechanisms. Lancet Infect Dis. 2005; 5(12):786-94. DOI: 10.1016/S1473-3099(05)70298-X. View

Gosmann C, Anahtar M, Handley S, Farcasanu M, Abu-Ali G, Bowman B . Lactobacillus-Deficient Cervicovaginal Bacterial Communities Are Associated with Increased HIV Acquisition in Young South African Women. Immunity. 2017; 46(1):29-37. PMC: 5270628. DOI: 10.1016/j.immuni.2016.12.013. View

Abdool Karim Q, Abdool Karim S, Frohlich J, Grobler A, Baxter C, Mansoor L . Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science. 2010; 329(5996):1168-74. PMC: 3001187. DOI: 10.1126/science.1193748. View

Kharsany A, Karim Q . HIV Infection and AIDS in Sub-Saharan Africa: Current Status, Challenges and Opportunities. Open AIDS J. 2016; 10:34-48. PMC: 4893541. DOI: 10.2174/1874613601610010034. View

Klatt N, Cheu R, Birse K, Zevin A, Perner M, Noel-Romas L . Vaginal bacteria modify HIV tenofovir microbicide efficacy in African women. Science. 2017; 356(6341):938-945. DOI: 10.1126/science.aai9383. View

Heffron R, McClelland R, Balkus J, Celum C, Cohen C, Mugo N . Efficacy of oral pre-exposure prophylaxis (PrEP) for HIV among women with abnormal vaginal microbiota: a post-hoc analysis of the randomised, placebo-controlled Partners PrEP Study. Lancet HIV. 2017; 4(10):e449-e456. PMC: 5649365. DOI: 10.1016/S2352-3018(17)30110-8. View

Masson L, Passmore J, Liebenberg L, Werner L, Baxter C, Arnold K . Genital inflammation and the risk of HIV acquisition in women. Clin Infect Dis. 2015; 61(2):260-9. PMC: 4565995. DOI: 10.1093/cid/civ298. View

Selhorst P, Masson L, Ismail S, Samsunder N, Garrett N, Mansoor L . Cervicovaginal Inflammation Facilitates Acquisition of Less Infectious HIV Variants. Clin Infect Dis. 2016; 64(1):79-82. PMC: 5159604. DOI: 10.1093/cid/ciw663. View

Ravel J, Gajer P, Abdo Z, Schneider G, Koenig S, McCulle S . Vaginal microbiome of reproductive-age women. Proc Natl Acad Sci U S A. 2010; 108 Suppl 1:4680-7. PMC: 3063603. DOI: 10.1073/pnas.1002611107. View

10.

Arnold K, Burgener A, Birse K, Romas L, Dunphy L, Shahabi K . Increased levels of inflammatory cytokines in the female reproductive tract are associated with altered expression of proteases, mucosal barrier proteins, and an influx of HIV-susceptible target cells. Mucosal Immunol. 2015; 9(1):194-205. DOI: 10.1038/mi.2015.51. View